重症下肢虚血薬の世界市場:販売動向2018

【英語タイトル】Global Critical Limb Ischemia Drug Sales Market Report 2018

QYResearchが出版した調査資料(QYR8051669)・商品コード:QYR8051669
・発行会社(調査会社):QYResearch
・発行日:2018年4月25日
・ページ数:112
・レポート言語:英語
・レポート形式:PDF
・納品方法:Eメール(受注後3営業日)
・調査対象地域:グローバル
・産業分野:Pharma & Healthcare
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD4,000 ⇒換算¥448,000見積依頼/購入/質問フォーム
Enterprise(同一法人内共有可)USD8,000 ⇒換算¥896,000見積依頼/購入/質問フォーム
販売価格オプションの説明
※お支払金額:換算金額(日本円)+消費税
※納期:即日〜2営業日(3日以上かかる場合は別途表記又はご連絡)
※お支払方法:納品日+5日以内に請求書を発行・郵送(請求書発行日より2ヶ月以内に銀行振込、振込先:三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能)
本調査レポートでは、重症下肢虚血薬の世界市場について調査・分析し、重症下肢虚血薬のメーカー別販売量、市場シェア分析、種類別販売分析(HC-016、JVS-100、NFx-101、NK-104 NP、その他)、用途別販売分析(病院、在宅ケア、その他)、地域別販売分析(米国、中国、欧州、日本、東南アジア、インド)、価格動向、企業動向、重症下肢虚血薬産業チェーン分析、世界市場規模予測などを含め、以下の構成でお届けいたします。

・重症下肢虚血薬市場概要
・重症下肢虚血薬のメーカー別販売量・メーカー別シェア
・重症下肢虚血薬の世界市場:種類別販売量(HC-016、JVS-100、NFx-101、NK-104 NP、その他)
・重症下肢虚血薬の世界市場:用途別販売量(病院、在宅ケア、その他)
・重症下肢虚血薬の世界市場:地域別販売量・市場シェア
・重症下肢虚血薬の米国市場規模
・重症下肢虚血薬の中国市場規模
・重症下肢虚血薬の欧州市場規模
・重症下肢虚血薬の日本市場規模
・重症下肢虚血薬の東南アジア市場規模
・重症下肢虚血薬のインド市場規模
・重症下肢虚血薬のメーカー別分析(企業概要、事業概要、製品概要、収益、価格等)
・重症下肢虚血薬のコスト分析・価格動向
・重症下肢虚血薬の産業チェーン(サプライチェーン分析)
・重症下肢虚血薬のマーケティング戦略・販売チャネル、流通業者
・重症下肢虚血薬市場への影響要因分析
・重症下肢虚血薬の世界市場予測
・重症下肢虚血薬の米国市場予測
・重症下肢虚血薬の中国市場予測
・重症下肢虚血薬の欧州市場予測
・重症下肢虚血薬の日本市場予測
・重症下肢虚血薬の東南アジア市場予測
・重症下肢虚血薬のインド市場予測
・重症下肢虚血薬の種類別世界市場予測(HC-016、JVS-100、NFx-101、NK-104 NP、その他)
・重症下肢虚血薬の用途別世界市場予測(病院、在宅ケア、その他)
...
【レポートの概要】

This report studies the global Critical Limb Ischemia Drug market status and forecast, categorizes the global Critical Limb Ischemia Drug market size (value & volume) by key players, type, application, and region. This report focuses on the top players in North America, Europe, China, Japan, Southeast Asia India and Other regions (Middle East & Africa, Central & South America).
In 2017, the global Critical Limb Ischemia Drug market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx.x % between 2018 and 2025.

The major players covered in this report
ReNeuron Group Plc
Symic Biomedical Inc
TikoMed AB
U.S. Stem Cell Inc
Kasiak Research Pvt Ltd
BiogenCell Ltd
Cynata Therapeutics Ltd
Hemostemix Inc
Neurofx Inc
Nissan Chemical Industries Ltd
Pharmicell Co Ltd
Pluristem Therapeutics Inc
Caladrius Biosciences Inc

Geographically, this report studies the key regions, focuses on product sales, value, market share and growth opportunity in these regions, covering
United States
Europe
China
Japan
Southeast Asia
India

The regional scope of the study is as follows:
North America
United States
Canada
Mexico
Asia-Pacific
China
India
Japan
South Korea
Australia
Indonesia
Singapore
Rest of Asia-Pacific
Europe
Germany
France
UK
Italy
Spain
Russia
Rest of Europe
Central & South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Saudi Arabia
Turkey
Rest of Middle East & Africa

On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into
HC-016
JVS-100
NFx-101
NK-104 NP
Others
On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate for each application, including
Hospital
Home Care
ASCs

The study objectives of this report are:
To analyze and study the global Critical Limb Ischemia Drug sales, value, status (2013-2017) and forecast (2018-2025);
To analyze the top players in North America, Europe, China, Japan, Southeast Asia and India, to study the sales, value and market share of top players in these regions.
Focuses on the key Critical Limb Ischemia Drug players, to study the sales, value, market share and development plans in future.
Focuses on the global key manufacturers, to define, describe and analyze the market competition landscape, SWOT analysis.
To define, describe and forecast the market by type, application and region.
To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints and risks.
To identify significant trends and factors driving or inhibiting the market growth.
To analyze the opportunities in the market for stakeholders by identifying the high growth segments.
To strategically analyze each submarket with respect to individual growth trend and their contribution to the market
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market
To strategically profile the key players and comprehensively analyze their growth strategies.

In this study, the years considered to estimate the market size of Critical Limb Ischemia Drug are as follows:
History Year: 2013-2017
Base Year: 2017
Estimated Year: 2018
Forecast Year 2018 to 2025

For the data information by region, company, type and application, 2017 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

Key Stakeholders
Critical Limb Ischemia Drug Manufacturers
Critical Limb Ischemia Drug Distributors/Traders/Wholesalers
Critical Limb Ischemia Drug Subcomponent Manufacturers
Industry Association
Downstream Vendors

Available Customizations
With the given market data, QYResearch offers customizations according to the company’s specific needs. The following customization options are available for the report:
Regional and country-level analysis of the Critical Limb Ischemia Drug market, by end-use.
Detailed analysis and profiles of additional market players.

【レポートの目次】

Table of Contents

Global Critical Limb Ischemia Drug Sales Market Report 2018
1 Critical Limb Ischemia Drug Market Overview
1.1 Product Overview and Scope of Critical Limb Ischemia Drug
1.2 Classification of Critical Limb Ischemia Drug by Product Category
1.2.1 Global Critical Limb Ischemia Drug Market Size (Sales) Comparison by Type (2013-2025)
1.2.2 Global Critical Limb Ischemia Drug Market Size (Sales) Market Share by Type (Product Category) in 2017
1.2.3 HC-016
1.2.4 JVS-100
1.2.5 NFx-101
1.2.6 NK-104 NP
1.2.7 Others
1.3 Global Critical Limb Ischemia Drug Market by Application/End Users
1.3.1 Global Critical Limb Ischemia Drug Sales (Volume) and Market Share Comparison by Application (2013-2025)
1.3.2 Hospital
1.3.3 Home Care
1.3.4 ASCs
1.4 Global Critical Limb Ischemia Drug Market by Region
1.4.1 Global Critical Limb Ischemia Drug Market Size (Value) Comparison by Region (2013-2025)
1.4.2 United States Critical Limb Ischemia Drug Status and Prospect (2013-2025)
1.4.3 Europe Critical Limb Ischemia Drug Status and Prospect (2013-2025)
1.4.4 China Critical Limb Ischemia Drug Status and Prospect (2013-2025)
1.4.5 Japan Critical Limb Ischemia Drug Status and Prospect (2013-2025)
1.4.6 Southeast Asia Critical Limb Ischemia Drug Status and Prospect (2013-2025)
1.4.7 India Critical Limb Ischemia Drug Status and Prospect (2013-2025)
1.5 Global Market Size (Value and Volume) of Critical Limb Ischemia Drug (2013-2025)
1.5.1 Global Critical Limb Ischemia Drug Sales and Growth Rate (2013-2025)
1.5.2 Global Critical Limb Ischemia Drug Revenue and Growth Rate (2013-2025)

2 Global Critical Limb Ischemia Drug Competition by Players/Suppliers, Type and Application
2.1 Global Critical Limb Ischemia Drug Market Competition by Players/Suppliers
2.1.1 Global Critical Limb Ischemia Drug Sales and Market Share of Key Players/Suppliers (2013-2018)
2.1.2 Global Critical Limb Ischemia Drug Revenue and Share by Players/Suppliers (2013-2018)
2.2 Global Critical Limb Ischemia Drug (Volume and Value) by Type
2.2.1 Global Critical Limb Ischemia Drug Sales and Market Share by Type (2013-2018)
2.2.2 Global Critical Limb Ischemia Drug Revenue and Market Share by Type (2013-2018)
2.3 Global Critical Limb Ischemia Drug (Volume and Value) by Region
2.3.1 Global Critical Limb Ischemia Drug Sales and Market Share by Region (2013-2018)
2.3.2 Global Critical Limb Ischemia Drug Revenue and Market Share by Region (2013-2018)
2.4 Global Critical Limb Ischemia Drug (Volume) by Application

3 United States Critical Limb Ischemia Drug (Volume, Value and Sales Price)
3.1 United States Critical Limb Ischemia Drug Sales and Value (2013-2018)
3.1.1 United States Critical Limb Ischemia Drug Sales and Growth Rate (2013-2018)
3.1.2 United States Critical Limb Ischemia Drug Revenue and Growth Rate (2013-2018)
3.1.3 United States Critical Limb Ischemia Drug Sales Price Trend (2013-2018)
3.2 United States Critical Limb Ischemia Drug Sales Volume and Market Share by Players (2013-2018)
3.3 United States Critical Limb Ischemia Drug Sales Volume and Market Share by Type (2013-2018)
3.4 United States Critical Limb Ischemia Drug Sales Volume and Market Share by Application (2013-2018)

4 Europe Critical Limb Ischemia Drug (Volume, Value and Sales Price)
4.1 Europe Critical Limb Ischemia Drug Sales and Value (2013-2018)
4.1.1 Europe Critical Limb Ischemia Drug Sales and Growth Rate (2013-2018)
4.1.2 Europe Critical Limb Ischemia Drug Revenue and Growth Rate (2013-2018)
4.1.3 Europe Critical Limb Ischemia Drug Sales Price Trend (2013-2018)
4.2 Europe Critical Limb Ischemia Drug Sales Volume and Market Share by Players (2013-2018)
4.3 Europe Critical Limb Ischemia Drug Sales Volume and Market Share by Type (2013-2018)
4.4 Europe Critical Limb Ischemia Drug Sales Volume and Market Share by Application (2013-2018)

5 China Critical Limb Ischemia Drug (Volume, Value and Sales Price)
5.1 China Critical Limb Ischemia Drug Sales and Value (2013-2018)
5.1.1 China Critical Limb Ischemia Drug Sales and Growth Rate (2013-2018)
5.1.2 China Critical Limb Ischemia Drug Revenue and Growth Rate (2013-2018)
5.1.3 China Critical Limb Ischemia Drug Sales Price Trend (2013-2018)
5.2 China Critical Limb Ischemia Drug Sales Volume and Market Share by Players (2013-2018)
5.3 China Critical Limb Ischemia Drug Sales Volume and Market Share by Type (2013-2018)
5.4 China Critical Limb Ischemia Drug Sales Volume and Market Share by Application (2013-2018)

6 Japan Critical Limb Ischemia Drug (Volume, Value and Sales Price)
6.1 Japan Critical Limb Ischemia Drug Sales and Value (2013-2018)
6.1.1 Japan Critical Limb Ischemia Drug Sales and Growth Rate (2013-2018)
6.1.2 Japan Critical Limb Ischemia Drug Revenue and Growth Rate (2013-2018)
6.1.3 Japan Critical Limb Ischemia Drug Sales Price Trend (2013-2018)
6.2 Japan Critical Limb Ischemia Drug Sales Volume and Market Share by Players (2013-2018)
6.3 Japan Critical Limb Ischemia Drug Sales Volume and Market Share by Type (2013-2018)
6.4 Japan Critical Limb Ischemia Drug Sales Volume and Market Share by Application (2013-2018)

7 Southeast Asia Critical Limb Ischemia Drug (Volume, Value and Sales Price)
7.1 Southeast Asia Critical Limb Ischemia Drug Sales and Value (2013-2018)
7.1.1 Southeast Asia Critical Limb Ischemia Drug Sales and Growth Rate (2013-2018)
7.1.2 Southeast Asia Critical Limb Ischemia Drug Revenue and Growth Rate (2013-2018)
7.1.3 Southeast Asia Critical Limb Ischemia Drug Sales Price Trend (2013-2018)
7.2 Southeast Asia Critical Limb Ischemia Drug Sales Volume and Market Share by Players (2013-2018)
7.3 Southeast Asia Critical Limb Ischemia Drug Sales Volume and Market Share by Type (2013-2018)
7.4 Southeast Asia Critical Limb Ischemia Drug Sales Volume and Market Share by Application (2013-2018)

8 India Critical Limb Ischemia Drug (Volume, Value and Sales Price)
8.1 India Critical Limb Ischemia Drug Sales and Value (2013-2018)
8.1.1 India Critical Limb Ischemia Drug Sales and Growth Rate (2013-2018)
8.1.2 India Critical Limb Ischemia Drug Revenue and Growth Rate (2013-2018)
8.1.3 India Critical Limb Ischemia Drug Sales Price Trend (2013-2018)
8.2 India Critical Limb Ischemia Drug Sales Volume and Market Share by Players (2013-2018)
8.3 India Critical Limb Ischemia Drug Sales Volume and Market Share by Type (2013-2018)
8.4 India Critical Limb Ischemia Drug Sales Volume and Market Share by Application (2013-2018)

9 Global Critical Limb Ischemia Drug Players/Suppliers Profiles and Sales Data
9.1 ReNeuron Group Plc
9.1.1 Company Basic Information, Manufacturing Base and Competitors
9.1.2 Critical Limb Ischemia Drug Product Category, Application and Specification
9.1.2.1 Product A
9.1.2.2 Product B
9.1.3 ReNeuron Group Plc Critical Limb Ischemia Drug Sales, Revenue, Price and Gross Margin (2013-2018)
9.1.4 Main Business/Business Overview
9.2 Symic Biomedical Inc
9.2.1 Company Basic Information, Manufacturing Base and Competitors
9.2.2 Critical Limb Ischemia Drug Product Category, Application and Specification
9.2.2.1 Product A
9.2.2.2 Product B
9.2.3 Symic Biomedical Inc Critical Limb Ischemia Drug Sales, Revenue, Price and Gross Margin (2013-2018)
9.2.4 Main Business/Business Overview
9.3 TikoMed AB
9.3.1 Company Basic Information, Manufacturing Base and Competitors
9.3.2 Critical Limb Ischemia Drug Product Category, Application and Specification
9.3.2.1 Product A
9.3.2.2 Product B
9.3.3 TikoMed AB Critical Limb Ischemia Drug Sales, Revenue, Price and Gross Margin (2013-2018)
9.3.4 Main Business/Business Overview
9.4 U.S. Stem Cell Inc
9.4.1 Company Basic Information, Manufacturing Base and Competitors
9.4.2 Critical Limb Ischemia Drug Product Category, Application and Specification
9.4.2.1 Product A
9.4.2.2 Product B
9.4.3 U.S. Stem Cell Inc Critical Limb Ischemia Drug Sales, Revenue, Price and Gross Margin (2013-2018)
9.4.4 Main Business/Business Overview
9.5 Kasiak Research Pvt Ltd
9.5.1 Company Basic Information, Manufacturing Base and Competitors
9.5.2 Critical Limb Ischemia Drug Product Category, Application and Specification
9.5.2.1 Product A
9.5.2.2 Product B
9.5.3 Kasiak Research Pvt Ltd Critical Limb Ischemia Drug Sales, Revenue, Price and Gross Margin (2013-2018)
9.5.4 Main Business/Business Overview
9.6 BiogenCell Ltd
9.6.1 Company Basic Information, Manufacturing Base and Competitors
9.6.2 Critical Limb Ischemia Drug Product Category, Application and Specification
9.6.2.1 Product A
9.6.2.2 Product B
9.6.3 BiogenCell Ltd Critical Limb Ischemia Drug Sales, Revenue, Price and Gross Margin (2013-2018)
9.6.4 Main Business/Business Overview
9.7 Cynata Therapeutics Ltd
9.7.1 Company Basic Information, Manufacturing Base and Competitors
9.7.2 Critical Limb Ischemia Drug Product Category, Application and Specification
9.7.2.1 Product A
9.7.2.2 Product B
9.7.3 Cynata Therapeutics Ltd Critical Limb Ischemia Drug Sales, Revenue, Price and Gross Margin (2013-2018)
9.7.4 Main Business/Business Overview
9.8 Hemostemix Inc
9.8.1 Company Basic Information, Manufacturing Base and Competitors
9.8.2 Critical Limb Ischemia Drug Product Category, Application and Specification
9.8.2.1 Product A
9.8.2.2 Product B
9.8.3 Hemostemix Inc Critical Limb Ischemia Drug Sales, Revenue, Price and Gross Margin (2013-2018)
9.8.4 Main Business/Business Overview
9.9 Neurofx Inc
9.9.1 Company Basic Information, Manufacturing Base and Competitors
9.9.2 Critical Limb Ischemia Drug Product Category, Application and Specification
9.9.2.1 Product A
9.9.2.2 Product B
9.9.3 Neurofx Inc Critical Limb Ischemia Drug Sales, Revenue, Price and Gross Margin (2013-2018)
9.9.4 Main Business/Business Overview
9.10 Nissan Chemical Industries Ltd
9.10.1 Company Basic Information, Manufacturing Base and Competitors
9.10.2 Critical Limb Ischemia Drug Product Category, Application and Specification
9.10.2.1 Product A
9.10.2.2 Product B
9.10.3 Nissan Chemical Industries Ltd Critical Limb Ischemia Drug Sales, Revenue, Price and Gross Margin (2013-2018)
9.10.4 Main Business/Business Overview
9.11 Pharmicell Co Ltd
9.12 Pluristem Therapeutics Inc
9.13 Caladrius Biosciences Inc

10 Critical Limb Ischemia Drug Maufacturing Cost Analysis
10.1 Critical Limb Ischemia Drug Key Raw Materials Analysis
10.1.1 Key Raw Materials
10.1.2 Price Trend of Key Raw Materials
10.1.3 Key Suppliers of Raw Materials
10.1.4 Market Concentration Rate of Raw Materials
10.2 Proportion of Manufacturing Cost Structure
10.2.1 Raw Materials
10.2.2 Labor Cost
10.2.3 Manufacturing Process Analysis of Critical Limb Ischemia Drug
10.3 Manufacturing Process Analysis of Critical Limb Ischemia Drug

11 Industrial Chain, Sourcing Strategy and Downstream Buyers
11.1 Critical Limb Ischemia Drug Industrial Chain Analysis
11.2 Upstream Raw Materials Sourcing
11.3 Raw Materials Sources of Critical Limb Ischemia Drug Major Manufacturers in 2017
11.4 Downstream Buyers

12 Marketing Strategy Analysis, Distributors/Traders
12.1 Marketing Channel
12.1.1 Direct Marketing
12.1.2 Indirect Marketing
12.1.3 Marketing Channel Development Trend
12.2 Market Positioning
12.2.1 Pricing Strategy
12.2.2 Brand Strategy
12.2.3 Target Client
12.3 Distributors/Traders List

13 Market Effect Factors Analysis
13.1 Technology Progress/Risk
13.1.1 Substitutes Threat
13.1.2 Technology Progress in Related Industry
13.2 Consumer Needs/Customer Preference Change
13.3 Economic/Political Environmental Change

14 Global Critical Limb Ischemia Drug Market Forecast (2018-2025)
14.1 Global Critical Limb Ischemia Drug Sales Volume, Revenue and Price Forecast (2018-2025)
14.1.1 Global Critical Limb Ischemia Drug Sales Volume and Growth Rate Forecast (2018-2025)
14.1.2 Global Critical Limb Ischemia Drug Revenue and Growth Rate Forecast (2018-2025)
14.1.3 Global Critical Limb Ischemia Drug Price and Trend Forecast (2018-2025)
14.2 Global Critical Limb Ischemia Drug Sales Volume, Revenue and Growth Rate Forecast by Region (2018-2025)
14.2.1 Global Critical Limb Ischemia Drug Sales Volume and Growth Rate Forecast by Regions (2018-2025)
14.2.2 Global Critical Limb Ischemia Drug Revenue and Growth Rate Forecast by Regions (2018-2025)
14.2.3 United States Critical Limb Ischemia Drug Sales Volume, Revenue and Growth Rate Forecast (2018-2025)
14.2.4 Europe Critical Limb Ischemia Drug Sales Volume, Revenue and Growth Rate Forecast (2018-2025)
14.2.5 China Critical Limb Ischemia Drug Sales Volume, Revenue and Growth Rate Forecast (2018-2025)
14.2.6 Japan Critical Limb Ischemia Drug Sales Volume, Revenue and Growth Rate Forecast (2018-2025)
14.2.7 Southeast Asia Critical Limb Ischemia Drug Sales Volume, Revenue and Growth Rate Forecast (2018-2025)
14.2.8 India Critical Limb Ischemia Drug Sales Volume, Revenue and Growth Rate Forecast (2018-2025)
14.3 Global Critical Limb Ischemia Drug Sales Volume, Revenue and Price Forecast by Type (2018-2025)
14.3.1 Global Critical Limb Ischemia Drug Sales Forecast by Type (2018-2025)
14.3.2 Global Critical Limb Ischemia Drug Revenue Forecast by Type (2018-2025)
14.3.3 Global Critical Limb Ischemia Drug Price Forecast by Type (2018-2025)
14.4 Global Critical Limb Ischemia Drug Sales Volume Forecast by Application (2018-2025)

15 Research Findings and Conclusion

16 Appendix
16.1 Methodology/Research Approach
16.1.1 Research Programs/Design
16.1.2 Market Size Estimation
16.1.3 Market Breakdown and Data Triangulation
16.2 Data Source
16.2.1 Secondary Sources
16.2.2 Primary Sources
16.3 Disclaimer

List of Tables and Figures

Figure Product Picture of Critical Limb Ischemia Drug
Figure Global Critical Limb Ischemia Drug Sales Volume Comparison (K Pcs) by Type (2013-2025)
Figure Global Critical Limb Ischemia Drug Sales Volume Market Share by Type (Product Category) in 2017
Figure HC-016 Product Picture
Figure JVS-100 Product Picture
Figure NFx-101 Product Picture
Figure NK-104 NP Product Picture
Figure Others Product Picture
Figure Global Critical Limb Ischemia Drug Sales Comparison (K Pcs) by Application (2013-2025)
Figure Global Sales Market Share of Critical Limb Ischemia Drug by Application in 2017
Figure Hospital Examples
Table Key Downstream Customer in Hospital
Figure Home Care Examples
Table Key Downstream Customer in Home Care
Figure ASCs Examples
Table Key Downstream Customer in ASCs
Figure Global Critical Limb Ischemia Drug Market Size (Million USD) by Regions (2013-2025)
Figure United States Critical Limb Ischemia Drug Revenue (Million USD) and Growth Rate (2013-2025)
Figure Europe Critical Limb Ischemia Drug Revenue (Million USD) and Growth Rate (2013-2025)
Figure China Critical Limb Ischemia Drug Revenue (Million USD) and Growth Rate (2013-2025)
Figure Japan Critical Limb Ischemia Drug Revenue (Million USD) and Growth Rate (2013-2025)
Figure Southeast Asia Critical Limb Ischemia Drug Revenue (Million USD) and Growth Rate (2013-2025)
Figure India Critical Limb Ischemia Drug Revenue (Million USD) and Growth Rate (2013-2025)
Figure Global Critical Limb Ischemia Drug Sales Volume (K Pcs) and Growth Rate (2013-2025)
Figure Global Critical Limb Ischemia Drug Revenue (Million USD) and Growth Rate (2013-2025)
Figure Global Market Major Players Critical Limb Ischemia Drug Sales Volume (K Pcs) (2013-2018)
Table Global Critical Limb Ischemia Drug Sales (K Pcs) of Key Players/Suppliers (2013-2018)
Table Global Critical Limb Ischemia Drug Sales Share by Players/Suppliers (2013-2018)
Figure 2017 Critical Limb Ischemia Drug Sales Share by Players/Suppliers
Figure 2017 Critical Limb Ischemia Drug Sales Share by Players/Suppliers
Figure Global Critical Limb Ischemia Drug Revenue (Million USD) by Players/Suppliers (2013-2018)
Table Global Critical Limb Ischemia Drug Revenue (Million USD) by Players/Suppliers (2013-2018)
Table Global Critical Limb Ischemia Drug Revenue Share by Players/Suppliers (2013-2018)
Table 2017 Global Critical Limb Ischemia Drug Revenue Share by Players
Table 2017 Global Critical Limb Ischemia Drug Revenue Share by Players
Table Global Critical Limb Ischemia Drug Sales (K Pcs) and Market Share by Type (2013-2018)
Table Global Critical Limb Ischemia Drug Sales Share (K Pcs) by Type (2013-2018)
Figure Sales Market Share of Critical Limb Ischemia Drug by Type (2013-2018)
Figure Global Critical Limb Ischemia Drug Sales Growth Rate by Type (2013-2018)
Table Global Critical Limb Ischemia Drug Revenue (Million USD) and Market Share by Type (2013-2018)
Table Global Critical Limb Ischemia Drug Revenue Share by Type (2013-2018)
Figure Revenue Market Share of Critical Limb Ischemia Drug by Type (2013-2018)
Figure Global Critical Limb Ischemia Drug Revenue Growth Rate by Type (2013-2018)
Table Global Critical Limb Ischemia Drug Sales Volume (K Pcs) and Market Share by Region (2013-2018)
Table Global Critical Limb Ischemia Drug Sales Share by Region (2013-2018)
Figure Sales Market Share of Critical Limb Ischemia Drug by Region (2013-2018)
Figure Global Critical Limb Ischemia Drug Sales Growth Rate by Region in 2017
Table Global Critical Limb Ischemia Drug Revenue (Million USD) and Market Share by Region (2013-2018)
Table Global Critical Limb Ischemia Drug Revenue Share (%) by Region (2013-2018)
Figure Revenue Market Share of Critical Limb Ischemia Drug by Region (2013-2018)
Figure Global Critical Limb Ischemia Drug Revenue Growth Rate by Region in 2017
Table Global Critical Limb Ischemia Drug Revenue (Million USD) and Market Share by Region (2013-2018)
Table Global Critical Limb Ischemia Drug Revenue Share (%) by Region (2013-2018)
Figure Revenue Market Share of Critical Limb Ischemia Drug by Region (2013-2018)
Figure Global Critical Limb Ischemia Drug Revenue Market Share by Region in 2017
Table Global Critical Limb Ischemia Drug Sales Volume (K Pcs) and Market Share by Application (2013-2018)
Table Global Critical Limb Ischemia Drug Sales Share (%) by Application (2013-2018)
Figure Sales Market Share of Critical Limb Ischemia Drug by Application (2013-2018)
Figure Global Critical Limb Ischemia Drug Sales Market Share by Application (2013-2018)
Figure United States Critical Limb Ischemia Drug Sales (K Pcs) and Growth Rate (2013-2018)
Figure United States Critical Limb Ischemia Drug Revenue (Million USD) and Growth Rate (2013-2018)
Figure United States Critical Limb Ischemia Drug Sales Price (USD/Pcs) Trend (2013-2018)
Table United States Critical Limb Ischemia Drug Sales Volume (K Pcs) by Players (2013-2018)
Table United States Critical Limb Ischemia Drug Sales Volume Market Share by Players (2013-2018)
Figure United States Critical Limb Ischemia Drug Sales Volume Market Share by Players in 2017
Table United States Critical Limb Ischemia Drug Sales Volume (K Pcs) by Type (2013-2018)
Table United States Critical Limb Ischemia Drug Sales Volume Market Share by Type (2013-2018)
Figure United States Critical Limb Ischemia Drug Sales Volume Market Share by Type in 2017
Table United States Critical Limb Ischemia Drug Sales Volume (K Pcs) by Application (2013-2018)
Table United States Critical Limb Ischemia Drug Sales Volume Market Share by Application (2013-2018)
Figure United States Critical Limb Ischemia Drug Sales Volume Market Share by Application in 2017
Figure Europe Critical Limb Ischemia Drug Sales (K Pcs) and Growth Rate (2013-2018)
Figure Europe Critical Limb Ischemia Drug Revenue (Million USD) and Growth Rate (2013-2018)
Figure Europe Critical Limb Ischemia Drug Sales Price (USD/Pcs) Trend (2013-2018)
Table Europe Critical Limb Ischemia Drug Sales Volume (K Pcs) by Players (2013-2018)
Table Europe Critical Limb Ischemia Drug Sales Volume Market Share by Players (2013-2018)
Figure Europe Critical Limb Ischemia Drug Sales Volume Market Share by Players in 2017
Table Europe Critical Limb Ischemia Drug Sales Volume (K Pcs) by Type (2013-2018)
Table Europe Critical Limb Ischemia Drug Sales Volume Market Share by Type (2013-2018)
Figure Europe Critical Limb Ischemia Drug Sales Volume Market Share by Type in 2017
Table Europe Critical Limb Ischemia Drug Sales Volume (K Pcs) by Application (2013-2018)
Table Europe Critical Limb Ischemia Drug Sales Volume Market Share by Application (2013-2018)
Figure Europe Critical Limb Ischemia Drug Sales Volume Market Share by Application in 2017
Figure China Critical Limb Ischemia Drug Sales (K Pcs) and Growth Rate (2013-2018)
Figure China Critical Limb Ischemia Drug Revenue (Million USD) and Growth Rate (2013-2018)
Figure China Critical Limb Ischemia Drug Sales Price (USD/Pcs) Trend (2013-2018)
Table China Critical Limb Ischemia Drug Sales Volume (K Pcs) by Players (2013-2018)
Table China Critical Limb Ischemia Drug Sales Volume Market Share by Players (2013-2018)
Figure China Critical Limb Ischemia Drug Sales Volume Market Share by Players in 2017
Table China Critical Limb Ischemia Drug Sales Volume (K Pcs) by Type (2013-2018)
Table China Critical Limb Ischemia Drug Sales Volume Market Share by Type (2013-2018)
Figure China Critical Limb Ischemia Drug Sales Volume Market Share by Type in 2017
Table China Critical Limb Ischemia Drug Sales Volume (K Pcs) by Application (2013-2018)
Table China Critical Limb Ischemia Drug Sales Volume Market Share by Application (2013-2018)
Figure China Critical Limb Ischemia Drug Sales Volume Market Share by Application in 2017
Figure Japan Critical Limb Ischemia Drug Sales (K Pcs) and Growth Rate (2013-2018)
Figure Japan Critical Limb Ischemia Drug Revenue (Million USD) and Growth Rate (2013-2018)
Figure Japan Critical Limb Ischemia Drug Sales Price (USD/Pcs) Trend (2013-2018)
Table Japan Critical Limb Ischemia Drug Sales Volume (K Pcs) by Players (2013-2018)
Table Japan Critical Limb Ischemia Drug Sales Volume Market Share by Players (2013-2018)
Figure Japan Critical Limb Ischemia Drug Sales Volume Market Share by Players in 2017
Table Japan Critical Limb Ischemia Drug Sales Volume (K Pcs) by Type (2013-2018)
Table Japan Critical Limb Ischemia Drug Sales Volume Market Share by Type (2013-2018)
Figure Japan Critical Limb Ischemia Drug Sales Volume Market Share by Type in 2017
Table Japan Critical Limb Ischemia Drug Sales Volume (K Pcs) by Application (2013-2018)
Table Japan Critical Limb Ischemia Drug Sales Volume Market Share by Application (2013-2018)
Figure Japan Critical Limb Ischemia Drug Sales Volume Market Share by Application in 2017
Figure Southeast Asia Critical Limb Ischemia Drug Sales (K Pcs) and Growth Rate (2013-2018)
Figure Southeast Asia Critical Limb Ischemia Drug Revenue (Million USD) and Growth Rate (2013-2018)
Figure Southeast Asia Critical Limb Ischemia Drug Sales Price (USD/Pcs) Trend (2013-2018)
Table Southeast Asia Critical Limb Ischemia Drug Sales Volume (K Pcs) by Players (2013-2018)
Table Southeast Asia Critical Limb Ischemia Drug Sales Volume Market Share by Players (2013-2018)
Figure Southeast Asia Critical Limb Ischemia Drug Sales Volume Market Share by Players in 2017
Table Southeast Asia Critical Limb Ischemia Drug Sales Volume (K Pcs) by Type (2013-2018)
Table Southeast Asia Critical Limb Ischemia Drug Sales Volume Market Share by Type (2013-2018)
Figure Southeast Asia Critical Limb Ischemia Drug Sales Volume Market Share by Type in 2017
Table Southeast Asia Critical Limb Ischemia Drug Sales Volume (K Pcs) by Application (2013-2018)
Table Southeast Asia Critical Limb Ischemia Drug Sales Volume Market Share by Application (2013-2018)
Figure Southeast Asia Critical Limb Ischemia Drug Sales Volume Market Share by Application in 2017
Figure India Critical Limb Ischemia Drug Sales (K Pcs) and Growth Rate (2013-2018)
Figure India Critical Limb Ischemia Drug Revenue (Million USD) and Growth Rate (2013-2018)
Figure India Critical Limb Ischemia Drug Sales Price (USD/Pcs) Trend (2013-2018)
Table India Critical Limb Ischemia Drug Sales Volume (K Pcs) by Players (2013-2018)
Table India Critical Limb Ischemia Drug Sales Volume Market Share by Players (2013-2018)
Figure India Critical Limb Ischemia Drug Sales Volume Market Share by Players in 2017
Table India Critical Limb Ischemia Drug Sales Volume (K Pcs) by Type (2013-2018)
Table India Critical Limb Ischemia Drug Sales Volume Market Share by Type (2013-2018)
Figure India Critical Limb Ischemia Drug Sales Volume Market Share by Type in 2017
Table India Critical Limb Ischemia Drug Sales Volume (K Pcs) by Application (2013-2018)
Table India Critical Limb Ischemia Drug Sales Volume Market Share by Application (2013-2018)
Figure India Critical Limb Ischemia Drug Sales Volume Market Share by Application in 2017
Table ReNeuron Group Plc Basic Information List
Table ReNeuron Group Plc Critical Limb Ischemia Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2013-2018)
Figure ReNeuron Group Plc Critical Limb Ischemia Drug Sales Growth Rate (2013-2018)
Figure ReNeuron Group Plc Critical Limb Ischemia Drug Sales Global Market Share (2013-2018)
Figure ReNeuron Group Plc Critical Limb Ischemia Drug Revenue Global Market Share (2013-2018)
Table Symic Biomedical Inc Basic Information List
Table Symic Biomedical Inc Critical Limb Ischemia Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2013-2018)
Figure Symic Biomedical Inc Critical Limb Ischemia Drug Sales Growth Rate (2013-2018)
Figure Symic Biomedical Inc Critical Limb Ischemia Drug Sales Global Market Share (2013-2018)
Figure Symic Biomedical Inc Critical Limb Ischemia Drug Revenue Global Market Share (2013-2018)
Table TikoMed AB Basic Information List
Table TikoMed AB Critical Limb Ischemia Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2013-2018)
Figure TikoMed AB Critical Limb Ischemia Drug Sales Growth Rate (2013-2018)
Figure TikoMed AB Critical Limb Ischemia Drug Sales Global Market Share (2013-2018
Figure TikoMed AB Critical Limb Ischemia Drug Revenue Global Market Share (2013-2018)
Table U.S. Stem Cell Inc Basic Information List
Table U.S. Stem Cell Inc Critical Limb Ischemia Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2013-2018)
Figure U.S. Stem Cell Inc Critical Limb Ischemia Drug Sales Growth Rate (2013-2018)
Figure U.S. Stem Cell Inc Critical Limb Ischemia Drug Sales Global Market Share (2013-2018)
Figure U.S. Stem Cell Inc Critical Limb Ischemia Drug Revenue Global Market Share (2013-2018)
Table Kasiak Research Pvt Ltd Basic Information List
Table Kasiak Research Pvt Ltd Critical Limb Ischemia Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2013-2018)
Figure Kasiak Research Pvt Ltd Critical Limb Ischemia Drug Sales Growth Rate (2013-2018)
Figure Kasiak Research Pvt Ltd Critical Limb Ischemia Drug Sales Global Market Share (2013-2018)
Figure Kasiak Research Pvt Ltd Critical Limb Ischemia Drug Revenue Global Market Share (2013-2018)
Table BiogenCell Ltd Basic Information List
Table BiogenCell Ltd Critical Limb Ischemia Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2013-2018)
Figure BiogenCell Ltd Critical Limb Ischemia Drug Sales Growth Rate (2013-2018)
Figure BiogenCell Ltd Critical Limb Ischemia Drug Sales Global Market Share (2013-2018
Figure BiogenCell Ltd Critical Limb Ischemia Drug Revenue Global Market Share (2013-2018)
Table Cynata Therapeutics Ltd Basic Information List
Table Cynata Therapeutics Ltd Critical Limb Ischemia Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2013-2018)
Figure Cynata Therapeutics Ltd Critical Limb Ischemia Drug Sales Growth Rate (2013-2018)
Figure Cynata Therapeutics Ltd Critical Limb Ischemia Drug Sales Global Market Share (2013-2018)
Figure Cynata Therapeutics Ltd Critical Limb Ischemia Drug Revenue Global Market Share (2013-2018)
Table Hemostemix Inc Basic Information List
Table Hemostemix Inc Critical Limb Ischemia Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2013-2018)
Figure Hemostemix Inc Critical Limb Ischemia Drug Sales Growth Rate (2013-2018)
Figure Hemostemix Inc Critical Limb Ischemia Drug Sales Global Market Share (2013-2018
Figure Hemostemix Inc Critical Limb Ischemia Drug Revenue Global Market Share (2013-2018)
Table Neurofx Inc Basic Information List
Table Neurofx Inc Critical Limb Ischemia Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2013-2018)
Figure Neurofx Inc Critical Limb Ischemia Drug Sales Growth Rate (2013-2018)
Figure Neurofx Inc Critical Limb Ischemia Drug Sales Global Market Share (2013-2018)
Figure Neurofx Inc Critical Limb Ischemia Drug Revenue Global Market Share (2013-2018)
Table Nissan Chemical Industries Ltd Basic Information List
Table Nissan Chemical Industries Ltd Critical Limb Ischemia Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2013-2018)
Figure Nissan Chemical Industries Ltd Critical Limb Ischemia Drug Sales Growth Rate (2013-2018)
Figure Nissan Chemical Industries Ltd Critical Limb Ischemia Drug Sales Global Market Share (2013-2018)
Figure Nissan Chemical Industries Ltd Critical Limb Ischemia Drug Revenue Global Market Share (2013-2018)
Table Pharmicell Co Ltd Basic Information List
Table Pluristem Therapeutics Inc Basic Information List
Table Caladrius Biosciences Inc Basic Information List
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Critical Limb Ischemia Drug
Figure Manufacturing Process Analysis of Critical Limb Ischemia Drug
Figure Critical Limb Ischemia Drug Industrial Chain Analysis
Table Raw Materials Sources of Critical Limb Ischemia Drug Major Players in 2017
Table Major Buyers of Critical Limb Ischemia Drug
Table Distributors/Traders List
Figure Global Critical Limb Ischemia Drug Sales Volume (K Pcs) and Growth Rate Forecast (2018-2025)
Figure Global Critical Limb Ischemia Drug Revenue (Million USD) and Growth Rate Forecast (2018-2025)
Figure Global Critical Limb Ischemia Drug Price (USD/Pcs) and Trend Forecast (2018-2025)
Table Global Critical Limb Ischemia Drug Sales Volume (K Pcs) Forecast by Regions (2018-2025)
Figure Global Critical Limb Ischemia Drug Sales Volume Market Share Forecast by Regions (2018-2025)
Figure Global Critical Limb Ischemia Drug Sales Volume Market Share Forecast by Regions in 2025
Table Global Critical Limb Ischemia Drug Revenue (Million USD) Forecast by Regions (2018-2025)
Figure Global Critical Limb Ischemia Drug Revenue Market Share Forecast by Regions (2018-2025)
Figure Global Critical Limb Ischemia Drug Revenue Market Share Forecast by Regions in 2025
Figure United States Critical Limb Ischemia Drug Sales Volume (K Pcs) and Growth Rate Forecast (2018-2025)
Figure United States Critical Limb Ischemia Drug Revenue (Million USD) and Growth Rate Forecast (2018-2025)
Figure Europe Critical Limb Ischemia Drug Sales Volume (K Pcs) and Growth Rate Forecast (2018-2025)
Figure Europe Critical Limb Ischemia Drug Revenue and Growth Rate Forecast (2018-2025)
Figure China Critical Limb Ischemia Drug Sales Volume (K Pcs) and Growth Rate Forecast (2018-2025)
Figure China Critical Limb Ischemia Drug Revenue (Million USD) and Growth Rate Forecast (2018-2025)
Figure Japan Critical Limb Ischemia Drug Sales Volume (K Pcs) and Growth Rate Forecast (2018-2025)
Figure Japan Critical Limb Ischemia Drug Revenue (Million USD) and Growth Rate Forecast (2018-2025)
Figure Southeast Asia Critical Limb Ischemia Drug Sales Volume (K Pcs) and Growth Rate Forecast (2018-2025)
Figure Southeast Asia Critical Limb Ischemia Drug Revenue (Million USD) and Growth Rate Forecast (2018-2025)
Figure India Critical Limb Ischemia Drug Sales Volume (K Pcs) and Growth Rate Forecast (2018-2025)
Figure India Critical Limb Ischemia Drug Revenue (Million USD) and Growth Rate Forecast (2018-2025)
Table Global Critical Limb Ischemia Drug Sales (K Pcs) Forecast by Type (2018-2025)
Figure Global Critical Limb Ischemia Drug Sales Volume Market Share Forecast by Type (2018-2025)
Table Global Critical Limb Ischemia Drug Revenue (Million USD) Forecast by Type (2018-2025)
Figure Global Critical Limb Ischemia Drug Revenue Market Share Forecast by Type (2018-2025)
Table Global Critical Limb Ischemia Drug Price (USD/Pcs) Forecast by Type (2018-2025)
Table Global Critical Limb Ischemia Drug Sales (K Pcs) Forecast by Application (2018-2025)
Figure Global Critical Limb Ischemia Drug Sales Market Share Forecast by Application (2018-2025)
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources


【レポートのキーワード】

重症下肢虚血薬、HC-016、JVS-100、NFx-101、NK-104 NP、病院、在宅ケア

★調査レポート[重症下肢虚血薬の世界市場:販売動向2018] (コード:QYR8051669)販売に関する免責事項を必ずご確認ください。
★調査レポート[重症下肢虚血薬の世界市場:販売動向2018]についてメールでお問い合わせ


◆H&Iグローバルリサーチのお客様(例)◆